id | C00001029 |
---|---|
Name | Chrysoeriol / Luteolin 3'-methyl ether |
CAS RN | 491-71-4 |
Standard InChI | InChI=1S/C16H12O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-7,17-19H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C16H12O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-7,17-19H,1H3 |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 3 |
By standard InChI | CHEMBL214321 |
---|---|
By standard InChI Main Layer | CHEMBL214321 |
By LinkDB | C04293 |
---|
By CAS RN | C007054 |
---|
class name | count |
---|---|
rosids | 16 |
asterids | 16 |
Embryophyta | 2 |
Liliopsida | 2 |
Euphyllophyta | 1 |
family name | count |
---|---|
Fabaceae | 15 |
Lamiaceae | 8 |
Asteraceae | 4 |
Poaceae | 1 |
Bignoniaceae | 1 |
Cannabaceae | 1 |
Scrophulariaceae | 1 |
Apiaceae | 1 |
Conocephalaceae | 1 |
Riellaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P33527 | Multidrug resistance-associated protein 1 | drugs | CHEMBL214321 |
CHEMBL1062295
(1)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL214321 |
CHEMBL1614079
(1)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL214321 |
CHEMBL2341203
(1)
CHEMBL2341207
(1)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL214321 |
CHEMBL1794585
(1)
|
0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL214321 |
CHEMBL1225717
(1)
|
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL214321 |
CHEMBL1614166
(1)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL214321 |
CHEMBL1614458
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL214321 |
CHEMBL1794486
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL214321 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL214321 |
CHEMBL2114843
(1)
|
0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL214321 |
CHEMBL2114807
(1)
|
4 / 2 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL214321 |
CHEMBL1614257
(2)
CHEMBL1614410
(1)
CHEMBL1614531 (2) |
1 / 3 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL214321 |
CHEMBL1059360
(1)
CHEMBL1059361
(1)
|
5 / 3 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL214321 |
CHEMBL1225718
(1)
|
4 / 4 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL214321 |
CHEMBL1225716
(1)
|
0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | CHEMBL214321 |
CHEMBL1062296
(1)
|
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL214321 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL214321 |
CHEMBL1614421
(1)
|
4 / 3 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | CHEMBL214321 |
CHEMBL1059364
(1)
CHEMBL1059365
(1)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL214321 |
CHEMBL1614257
(2)
CHEMBL1614531
(2)
|
2 / 5 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C007054 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | chrysoeriol results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
C007054 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | chrysoeriol inhibits the reaction [Benzo(a)pyrene binds to AHR protein] |
affects binding
/ decreases reaction |
protein |
20553787
|
C007054 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20553787
|
C007054 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20553787
|
C007054 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20553787
|
C007054 | 4543 |
MTNR1A
MEL-1A-R MT1 |
melatonin receptor 1A | chrysoeriol binds to MTNR1A protein |
affects binding
|
protein |
20399199
|
C007054 | 4544 |
MTNR1B
FGQTL2 MEL-1B-R MT2 |
melatonin receptor 1B | chrysoeriol binds to MTNR1B protein |
affects binding
|
protein |
20399199
|
C007054 | 4835 |
NQO2
DHQV DIA6 NMOR2 QR2 |
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Ubiquinone Q2] |
decreases reaction
/ increases oxidation / increases reduction |
protein |
20399199
|
C007054 | 4835 |
NQO2
DHQV DIA6 NMOR2 QR2 |
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3] |
decreases reaction
/ increases oxidation / increases reduction |
protein |
20399199
|
C007054 | 4835 |
NQO2
DHQV DIA6 NMOR2 QR2 |
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Ubiquinone Q2] |
decreases reaction
/ increases oxidation / increases reduction |
protein |
20399199
|
C007054 | 4835 |
NQO2
DHQV DIA6 NMOR2 QR2 |
NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) | chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3] |
decreases reaction
/ increases oxidation / increases reduction |
protein |
20399199
|
OMIM | preferred title | UniProt |
---|---|---|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#114500 | Colorectal cancer; crc |
P84022
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00027 | Ovarian cancer |
P38398
(related)
|
H00031 | Breast cancer |
P38398
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|